The CFPB Medical Debt Credit-Reporting Rule

In January 2025, the Consumer Financial Protection Bureau finalized a rule sharply restricting the appearance of medical debt on consumer credit reports. This page covers the rule, what it does and doesn't change, and its likely effect on medical-debt-driven bankruptcy filings.

What the rule does

The CFPB rule prohibits most medical debt from being included on consumer credit reports:

• Removal of existing medical debt from credit reports as of the effective date (rolling implementation through 2025)
• Prohibition on future reporting of medical debt by furnishers (collection agencies, hospitals, providers)
• Limited exceptions for medical debt that is also tied to non-medical credit (e.g., a medical-debt-related credit card)

What the rule does NOT do

The rule is about credit reporting. It does NOT:

• Eliminate the underlying debt — medical debt remains owed and collectible
• Stop collection lawsuits
• Stop wage garnishment after a judgment
• Prevent medical providers from refusing future service for unpaid bills
• Affect medical debt in bankruptcy — bankruptcy treatment is unchanged

Effect on bankruptcy filings

The rule's primary effect is on credit-score recovery for households with medical debt. Many bankruptcy filers historically were motivated in part by credit-score damage from reported medical debt. The CFPB rule:

• Reduces the credit-score motivator
• May modestly reduce non-essential bankruptcy filings (those primarily driven by credit-score concerns)
• Does NOT reduce filings driven by collection lawsuits, wage garnishment, or inability to pay

The likely net effect is a modest decline in medical-debt-driven Chapter 7 filings (perhaps 5-10%) over the rule's first 2-3 years of full implementation. Cases driven by active collection litigation or garnishment will continue at the same rate.

Legal challenges

The rule has faced legal challenges from credit-reporting industry groups arguing the CFPB exceeded its authority under the Fair Credit Reporting Act. Litigation is ongoing as of this writing. The rule's ultimate scope will depend on how courts resolve these challenges.